Cipla Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Glimda-MV 2 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glimda-MV 2 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimda-MV 2 Tablet SR is to be taken empty stomach.
Glimda-MV 2 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimda-MV 2 Tablet SR is a combination medication containing Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, in combination with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, Metformin lowers glucose production in the liver and improves insulin sensitivity, and Voglibose reduces postprandial glucose levels. This medication is not suitable for treating type 1 DM.
Common side effects of Glimda-MV 2 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your doctor or healthcare professional for guidance.
Glimda-MV 2 Tablet SR should be avoided in patients with known allergies to its components or excipients. Additionally, it is contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
No, it is not recommended to consume alcohol while taking Glimda-MV 2 Tablet SR. This may increase the risk of hypoglycemia and lactic acidosis. Consult your doctor or healthcare professional for personalized advice on alcohol consumption.
Yes, Glimda-MV 2 Tablet SR can cause hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. Regular monitoring of blood sugar levels is crucial. Always carry glucose tablets, honey, or fruit juice with you to manage hypoglycemia.
Store Glimda-MV 2 Tablet SR in its original packaging, tightly closed. Dispose of unused medication according to the instructions provided on the pack or label. Ensure that it is not consumed by pets, children, or other individuals.